In: European Heart Journal, 2008, vol. 29, no. 6, p. 766-776
|
In: Trials, 2014, vol. 15, no. 1, p. 9
Background: Second-generation everolimus-eluting stents (EES) and third generation biolimus-eluting stents (BES) have been shown to be superior to first-generation paclitaxel-eluting stents (PES) and second-generation sirolimus-eluting stents (SES). However, neointimal proliferation and very late stent thrombosis is still an unresolved issue of drug-eluting stent (DES) implantation overall. The...
|
In: European Heart Journal, 2004, vol. 25, no. 7, p. 565-570
|
In: European Heart Journal, 2015, vol. 36, no. 38, p. 2608-2620
|
In: European Journal of Cardio-Thoracic Surgery, 2015, vol. 47, no. 5, p. 860-861
|
In: European Heart Journal, 2013, vol. 34, no. 45, p. 3501-3507
|
In: European Journal of Cardio-Thoracic Surgery, 2011, vol. 40, no. 6, p. 1550-1550
|
In: European Journal of Cardio-Thoracic Surgery, 2012, vol. 41, no. 4, p. e25-e31
|
In: European Journal of Cardio-Thoracic Surgery, 2011, vol. 40, no. 1, p. 233-239
|
In: European Heart Journal, 2012, vol. 33, no. 13, p. 1589-1597
|